ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $58,800 | -89.7% | 60,000 | +26.2% | 0.08% | -60.1% |
Q3 2021 | $573,000 | -58.0% | 47,534 | -26.2% | 0.21% | -53.8% |
Q2 2021 | $1,363,000 | -24.6% | 64,434 | 0.0% | 0.45% | -35.7% |
Q1 2021 | $1,807,000 | +121.2% | 64,434 | +105.0% | 0.70% | +13.3% |
Q4 2020 | $817,000 | – | 31,434 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |